GlassScriptPhysician profile
Eiriny T Eskander
NPI 1154584183
$870.42
in general payments reported to CMS, 2019-2025
17 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $55.76 · 2021: $47.99 · 2022: $30.49 · 2023: $62.78 · 2024: $288 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $143.83 | 2019-2025 | Ozempic |
| Dexcom, INC. | $104.20 | 2019-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $95.63 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Mannkind Corporation | $78.02 | 2019 | |
| Amgen INC. | $77.53 | 2023-2024 | Evenity, Prolia |
| Tandem Diabetes Care, INC. | $71.30 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $44.71 | 2024 | Freestyle Libre 3 |
| Insulet Corporation | $43.42 | 2023-2024 | Omnipod |
| Medtronic Minimed, INC. | $42.72 | 2019 | |
| Corcept Therapeutics | $27.59 | 2024 | Korlym |
| Abbvie INC. | $27.56 | 2021 | |
| Sequel Med Tech, LLC | $27.17 | 2025 | Twiist |
| Senseonics, Incorporated | $20.00 | 2020 | |
| Pfizer INC. | $18.91 | 2020 | |
| Xeris Pharmaceuticals, INC. | $17.63 | 2024 | Gvoke Hypopen |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.85 | 2020 | |
| Radius Health, INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eiriny Eskander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.